The DOI matches its Crossref record; 116 of the 118 references it cites were found in a registry or an index.
Protein biomarker discovery and validation: the long and uncertain path to clinical utility
Abstract
Better biomarkers are urgently needed to improve diagnosis, guide molecularly targeted therapy and monitor activity and therapeutic response across a wide spectrum of disease. Proteomics methods based on mass spectrometry hold special promise for the discovery of novel biomarkers that might form the foundation for new clinical blood tests, but to date their contribution to the diagnostic armamentarium has been disappointing. This is due in part to the lack of a coherent pipeline connecting marker discovery with well-established methods for validation. Advances in methods and technology now enable construction of a comprehensive biomarker pipeline from six essential process components: candidate discovery, qualification, verification, research assay optimization, biomarker validation and commercialization. Better understanding of the overall process of biomarker discovery and validation and of the challenges and strategies inherent in each phase should improve experimental study design, in turn increasing the efficiency of biomarker development and facilitating the delivery and deployment of novel clinical tests.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, the MS detection of low-abundance proteins remains an unsolved challenge due to high dynamic range of the human proteome8–10.”
From Nanoproteomics enables proteoform-resolved analysis of low-abundance proteins in human serum (2020) · cites this paper as [9]
In the citing paper
“Front-end protein enrichment strategies are therefore required to specifically capture and enrich low-abundance proteins from the complex biological milieu prior to MS analysis9,11.”
From Nanoproteomics enables proteoform-resolved analysis of low-abundance proteins in human serum (2020) · cites this paper as [9]
In the citing paper
“In particular, the human blood proteome, a circulating representation of all pathophysiological processes, is immensely complex and the huge dynamic range of the blood proteome (1012) dominated by the presence of numerous highly abundant proteins, such as human serum albumin (HSA), makes the detection of low-abundance proteins extremely difficult9,10.”
From Nanoproteomics enables proteoform-resolved analysis of low-abundance proteins in human serum (2020) · cites this paper as [9]
In the citing paper
“additional sources of uncertainty may arise from processes such as protein quantification in bottom-up proteomics (Rifai et al., 2006; Plubell et al., 2022) as measurements are made at the peptide level and isoforms can be difficult to identify (Forshed et al., 2011; Webb-Robertson et al., 2014).”
From Missing data in multi-omics integration: Recent advances through artificial intelligence (2023) · cites this paper as Rifai et al., 2006
Citations
Cites
STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT
Martin Bland, J., & Altman, D. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90837-8 · Cited by 47,965
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Beckett, A. H., Rowland, M., & TURNER, P. (1965) · The Lancet · doi:10.1016/s0140-6736(65)91037-8 · Cited by 16,917
Practical Statistics for Medical Research.
Walter, S., & Altman, D. G. (1992) · Biometrics · doi:10.2307/2532320 · Cited by 11,666
Mass spectrometry-based proteomics
Aebersold, R., & Mann, M. (2003) · Nature · doi:10.1038/nature01511 · Cited by 6,955
Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine
ZWEIG, M. H., & Campbell, G. (1993) · Clinical Chemistry · doi:10.1093/clinchem/39.4.561 · Cited by 6,595
Practical Statistics for Medical Research.
Bartko, J. J., & Altman, D. G. (1992) · Journal of the American Statistical Association · doi:10.2307/2290246 · Cited by 4,834
Anderson, N. L., & Anderson, N. G. (2002) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r200007-mcp200 · Cited by 4,414
Tissue microarrays for high-throughput molecular profiling of tumor specimens
Kononen, J., Bubendorf, L., Kallionimeni, A., Barlund, M. T., Schraml, P., Leighton, S. B., Torhorst, J. K. H., Mihatsch, M. J., Sauter, G., & Kallionimeni, O.-P. (1998) · Nature Medicine · doi:10.1038/nm0798-844 · Cited by 4,101
Flagged first, then by citations
2 of the 118 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Entertainment Industry Foundation, Women's Cancer Research Fund Breast Cancer Biomarker Discovery Project. http://www.eifoundation.org/national/wcrf/press/article2005-10-04.html .
- International Standards Organization, I.O.F.S. Accuracy (Trueness and Precision) of Measurement Methods and Results (ISO 5725)-Part 1: General Principles and Definitions (ISO, Geneva, 1994).
Cited by
Sorted by citations
Items 301–400 of 1,000
Lin, D., Alborn, W. E., Slebos, R. J. C., & Liebler, D. C. (2013) · Journal of Proteome Research · doi:10.1021/pr400877e · Cited by 77
Nanotechniques in proteomics: Protein microarrays and novel detection platforms
González‐González, M., Jara‐Acevedo, R., Matarraz, S., Jara‐Acevedo, M., Sánchez‐Paradinas, S., Sayagués, J. M., Órfão, A., & Fuentes, M. (2011) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2011.07.009 · Cited by 77
MRM for the verification of cancer biomarker proteins: recent applications to human plasma and serum
Chambers, A. G., Percy, A. J., Simon, R., & Borchers, C. H. (2014) · Expert Review of Proteomics · doi:10.1586/14789450.2014.877346 · Cited by 77
Updating the International IgA Nephropathy Prediction Tool for use in children
Barbour, S. J., Coppo, R., Er, L., Russo, M. L., Liu, Z., Ding, J., Katafuchi, R., Yoshikawa, N., Xu, H. M., Kagami, S., et al. (2020) · Kidney International · doi:10.1016/j.kint.2020.10.033 · Cited by 79
Mukherjee, S., Mukherjee, A., Bytešníková, Z., Ashrafi, A. M., Richtera, L., & Adam, V. (2024) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2024.116050 · Cited by 77
Simultaneous detection of two lung cancer biomarkers using dual-color fluorescence quantum dots
Li, H., Cao, Z., Zhang, Y., Lau, C., & Lu, J. (2011) · The Analyst · doi:10.1039/c0an00704h · Cited by 77
Connective Tissue-Activating Peptide III: A Novel Blood Biomarker for Early Lung Cancer Detection
Yee, J., Sadar, M. D., Sin, D. D., Kuzyk, M. A., Xing, L., Kondra, J., McWilliams, A. M., Man, S. F. P., & Lam, S. C. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.4233 · Cited by 78
Nakorchevsky, A., Hewel, J. A., Kurian, S. M., Mondala, T. S., Campbell, D., Head, S. R., Marsh, C. L., Yates, J. R., & Salomon, D. R. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009060628 · Cited by 77
Rauf, S., Mishra, G. K., Azhar, J., Mishra, R. K., Goud, K. Y., Nawaz, M. A. H., Marty, J., & Hayat, A. (2018) · Analytical Biochemistry · doi:10.1016/j.ab.2018.01.007 · Cited by 76
Tan, H. T., Lee, Y. H., & Chung, M. C. M. (2012) · Mass Spectrometry Reviews · doi:10.1002/mas.20356 · Cited by 77
The evolving role of mass spectrometry in cancer biomarker discovery
Wang, P., Whiteaker, J. R., & Paulovich, A. G. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.12.8634 · Cited by 76
Technology Insight: biomarker development in acute kidney injury—what can we anticipate?
Molitoris, B. A., Melnikov, V. Y., Okusa, M. D., & Himmelfarb, J. (2008) · Nature Reviews Nephrology · doi:10.1038/ncpneph0723 · Cited by 77
Shen, X., Shen, S., Li, J., Hu, Q., Nie, L., Tu, C., Wang, X., Poulsen, D. J., Orsburn, B. C., Wang, J., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1800541115 · Cited by 76
Differential expression of miR‐21, miR‐125b and miR‐191 in breast cancer tissue
Mar‐Aguilar, F., Luna-Aguirre, C. M., MORENO‐ROCHA, J. C., ARAIZA‐CHÁVEZ, J., Treviño, V., Rodrı́guez-Padilla, C., & Reséndez‐Pérez, D. (2012) · Asia-Pacific Journal of Clinical Oncology · doi:10.1111/j.1743-7563.2012.01548.x · Cited by 75
Shen, X., Shen, S., Li, J., Hu, Q., Nie, L., Tu, C., Wang, X., Orsburn, B. C., Wang, J., & Qu, J. (2017) · Journal of Proteome Research · doi:10.1021/acs.jproteome.7b00061 · Cited by 73
The role of electrophoresis in disease biomarker discovery
Issaq, H. J., & Veenstra, T. D. (2007) · Electrophoresis · doi:10.1002/elps.200600834 · Cited by 74
Qin, W., Ho, L., Wang, J., Peskind, E. R., & Pasinetti, G. M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004183 · Cited by 75
Investigation of lung cancer biomarkers by hyphenated separation techniques and chemometrics
Buszewski, B., Ulanowska, A., Kowalkowski, T., & Cieśliński, K. (2011) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2011.769 · Cited by 74
The Use of Selected Reaction Monitoring in Quantitative Proteomics
Holman, S. W., Sims, P. F. G., & Eyers, C. E. (2012) · Bioanalysis · doi:10.4155/bio.12.126 · Cited by 83
Measurement and Quality Control Issues in Multiplex Protein Assays: A Case Study
Ellington, A. A., Kullo, I. J., Bailey, K. R., & Klee, G. G. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.120717 · Cited by 75
biosigner: A New Method for the Discovery of Significant Molecular Signatures from Omics Data
Rinaudo, P., Boudah, S., Junot, C., & Thévenot, E. (2016) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2016.00026 · Cited by 81
Microfluidics for Protein Biophysics
Charmet, J., Arosio, P., & Knowles, T. P. J. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.12.015 · Cited by 74
Advances in high-resolution quantitative proteomics: implications for clinical applications
Gallien, S., & Domon, B. (2015) · Expert Review of Proteomics · doi:10.1586/14789450.2015.1069188 · Cited by 73
A systematic review of proteomic biomarkers in oral squamous cell cancer
Pillai, J., Chincholkar, T., Dixit, R., & Pandey, M. (2021) · World Journal of Surgical Oncology · doi:10.1186/s12957-021-02423-y · Cited by 73
Kobeissy, F. H., Sadasivan, S., Oli, M. W., Robinson, G., Larner, S. F., Zhang, Z., Hayes, R. L., & Wang, K. (2008) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200800011 · Cited by 73
High-content affinity-based proteomics: unlocking protein biomarker discovery
Brody, E. N., Gold, L., Lawn, R. M., Walker, J. J., & Zichi, D. (2010) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.10.89 · Cited by 74
An overview of proteomic and metabolomic technologies and their application to pregnancy research
Horgan, R., Clancy, O., Myers, J., & Baker, P. N. (2008) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2008.01997.x · Cited by 73
Chang, J. W., Kang, U., Kim, D., Yi, J. K., Lee, J. W., Noh, D., Lee, C., & Yu, M. (2007) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200780049 · Cited by 75
What Room for Two-Dimensional Gel-Based Proteomics in a Shotgun Proteomics World?
Marcus, K., Lelong, C., & Rabilloud, T. (2020) · Proteomes · doi:10.3390/proteomes8030017 · Cited by 75
Tissue culture‐based breast cancer biomarker discovery platform
Kulasingam, V., & Diamandis, E. P. (2008) · International Journal of Cancer · doi:10.1002/ijc.23844 · Cited by 71
The Circulating Biomarkers League: Combining miRNAs with Cell-Free DNAs and Proteins
Felekkis, K. N., & Papaneophytou, C. P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063403 · Cited by 73
Agoston, D. V., Gyorgy, A. B., Eidelman, O., & Pollard, H. B. (2009) · Journal of Neurotrauma · doi:10.1089/neu.2008.0724 · Cited by 71
Yang, H., Oh, C.-K., Amal, H., Wishnok, J. S., Lewis, S., Schahrer, E., Trudler, D., Nakamura, T., Tannenbaum, S. R., & Lipton, S. A. (2022) · Science Advances · doi:10.1126/sciadv.ade0764 · Cited by 70
Clinical Usefulness of Proteomics in Inflammatory Bowel Disease: A Comprehensive Review
Gisbert, J. P., & Chaparro, M. (2018) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjy158 · Cited by 75
Imaging mass spectrometry in biomarker discovery and validation
Schwamborn, K. (2012) · Journal of Proteomics · doi:10.1016/j.jprot.2012.06.015 · Cited by 69
Biomarkers in pharmacology and drug discovery
Anderson, D. C., & Kodukula, K. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.08.026 · Cited by 72
Early identification of cardiovascular risk using genomics and proteomics
Kullo, I. J., & Cooper, L. T. (2010) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.53 · Cited by 73
The Knowledge-Integrated Network Biomarkers Discovery for Major Adverse Cardiac Events
Jin, G., Zhou, X., Wang, H., Zhao, H. C., Cui, K., Zhang, X.-S., Chen, L., Hazen, S. L., Li, K. C., & Wong, S. T. C. (2008) · Journal of Proteome Research · doi:10.1021/pr8002886 · Cited by 70
The application of quantification techniques in proteomics for biomedical research
Rodríguez‐Suárez, E., & Whetton, A. D. (2012) · Mass Spectrometry Reviews · doi:10.1002/mas.21347 · Cited by 72
The Current Status of Molecular Biomarkers for Inflammatory Bowel Disease
Alghoul, Z., Yang, C., & Merlin, D. (2022) · Biomedicines · doi:10.3390/biomedicines10071492 · Cited by 72
Pan, S., Rush, A. J., Peskind, E. R., Galasko, D., Chung, K. A., Quinn, J. F., Jankovic, J. J., Leverenz, J. B., Zabetian, C. P., Pan, C., et al. (2008) · Journal of Proteome Research · doi:10.1021/pr700630x · Cited by 69
Gerszten, R. E., Asnani, A. H., & Carr, S. A. (2011) · Circulation Research · doi:10.1161/circresaha.110.225003 · Cited by 71
Self-citationValidation and verification of measurement methods in clinical chemistry
Theodorsson, E. (2012) · Bioanalysis · doi:10.4155/bio.11.311 · Cited by 68
Predicting Intermediate Phenotypes in Asthma Using Bronchoalveolar Lavage‐Derived Cytokines
Brasier, A. R., Victor, S. S., Ju, H., Busse, W. W., Curran‐Everett, D., Bleecker, E. R., Castro, M., Chung, K. F., Gaston, B. M., Israel, E., et al. (2010) · Clinical and Translational Science · doi:10.1111/j.1752-8062.2010.00204.x · Cited by 68
McDonald, S. J., Shultz, S. R., & Agoston, D. V. (2021) · Journal of Neurotrauma · doi:10.1089/neu.2021.0011 · Cited by 70
Proteomic discovery of non-invasive biomarkers of localized prostate cancer using mass spectrometry
Khoo, A., Liu, L., Nyalwidhe, J. O., Semmes, O. J., Vesprini, D., Downes, M. R., Boutros, P. C., Liu, S. K., & Kislinger, T. (2021) · Nature Reviews Urology · doi:10.1038/s41585-021-00500-1 · Cited by 69
Suarez-Cortes, T. M., Merino-Inda, N., & Benitez-del-Castillo, J. M. (2022) · Experimental Eye Research · doi:10.1016/j.exer.2022.109121 · Cited by 72
The Present and Future of Prostate Cancer Urine Biomarkers
Rigau, M., Oliván, M., García, M., Sequeiros, T., Montes, M., Colás, E., Llauradó, M., Planas, J., de Torres, I. M., Moróte, J., et al. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140612620 · Cited by 68
Aguilar‐Mahecha, A., Kuzyk, M. A., Domański, D., Borchers, C. H., & Basik, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038290 · Cited by 68
Zhao, S., Ma, W., Xu, L., Wu, X., Kuang, H., Wang, L., & Xu, C. (2015) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2015.01.056 · Cited by 68
The Riddle of Protein Diagnostics: Future Bleak or Bright?
Anderson, N. L., Ptolemy, A. S., & Rifai, N. (2012) · Clinical Chemistry · doi:10.1373/clinchem.2012.184705 · Cited by 68
Self-citationIdentification of urine protein biomarkers with the potential for early detection of lung cancer
Zhang, H., Cao, J., Li, L., Liu, Y., Zhao, H., Li, N., Li, B., Zhang, A., Huang, H., Chen, S., et al. (2015) · Scientific Reports · doi:10.1038/srep11805 · Cited by 69
Computational Mass Spectrometry–Based Proteomics
Käll, L., & Vitek, O. (2011) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002277 · Cited by 70
Ackermann, B. L., Berna, M. J., Eckstein, J. A., Ott, L. W., & Chaudhary, A. K. (2008) · Annual Review of Analytical Chemistry · doi:10.1146/annurev.anchem.1.031207.112855 · Cited by 67
Lv, H., Jiang, F., Guan, D., Lu, C. C., Guo, B., Chan, C., Peng, S., Liu, B.-Q., Guo, W., Zhu, H., et al. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17122018 · Cited by 67
Martínez-García, E., Lesur, A., Devis, L., Cabrera, S., Matías‐Guiu, X., Hirschfeld, M., Asberger, J., van Oostrum, J., de Cal, M. C., Gómez‐Tato, A., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0474 · Cited by 67
Biomarkers for Aging Identified in Cross-sectional Studies Tend to Be Non-causative
Nelson, P. G., Promislow, D. E. L., & Masel, J. (2020) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glz174 · Cited by 65
Microfluidic Nanoparticle Separation for Precision Medicine
Lan, Z., Chen, R., Zou, D., & Zhao, C. (2024) · Advanced Science · doi:10.1002/advs.202411278 · Cited by 68
MicroRNAs in Head and Neck Cancer
John, K., Wu, J. J., Lee, B.-W., & Farah, C. S. (2013) · International Journal of Dentistry · doi:10.1155/2013/650218 · Cited by 66
Microfluidic array platform for simultaneous lipid bilayer membrane formation
Zagnoni, M., Sandison, M. E., & Morgan, H. (2008) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2008.07.022 · Cited by 66
Plasmonic ELISA based on the controlled growth of silver nanoparticles
Xuan, Z., Li, M., Rong, P., Wang, W., Li, Y., & Liu, D. (2016) · Nanoscale · doi:10.1039/c6nr06079j · Cited by 66
Liu, B., Ni, H., Zhang, D., Wang, D., Fu, D., Chen, H., Gu, Z., & Zhao, X. (2017) · ACS Sensors · doi:10.1021/acssensors.7b00310 · Cited by 66
Pavithra, M. K., Muruganand, S., & Chokkalingam, P. (2017) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2017.10.177 · Cited by 66
Validation and verification of predictive salivary biomarkers for oral health
Bostancı, N., Mitsakakis, K., Afacan, B., Bao, K., Johannsen, B., Baumgartner, D., Müller, L., Kotolová, H., Emingil, G., & Karpíšek, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-85120-w · Cited by 70
Protein corona fingerprinting to differentiate sepsis from non-infectious systemic inflammation
Papafilippou, L., Claxton, A., Dark, P. M., Kostarelos, K., & Hadjidemetriou, M. (2020) · Nanoscale · doi:10.1039/d0nr02788j · Cited by 65
Miyamoto, M., Yoshida, Y., Taguchi, I., Nagasaka, Y., Tasaki, M., Zhang, Y., Xu, B., Nameta, M., Sezaki, H., Cuéllar, L. M., et al. (2007) · Journal of Proteome Research · doi:10.1021/pr070203n · Cited by 65
microRNAs and the regulation of neuronal plasticity under stress conditions
Schouten, M., Aschrafi, A., Bielefeld, P., Doxakis, E., & Fitzsimons, C. P. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.02.065 · Cited by 69
Parkinson’s Disease Biomarkers: Perspective from the NINDS Parkinson’s Disease Biomarkers Program
Gwinn, K. A., David, K. K., Swanson‐Fischer, C., Albin, R. L., Hillaire‐Clarke, C. S., Sieber, B.-A., Lungu, C., Bowman, F. D., Alcalay, R. N., Babcock, D., et al. (2017) · Biomarkers in Medicine · doi:10.2217/bmm-2016-0370 · Cited by 65
de Ronde, M. W. J., Ruijter, J. M., Moerland, P. D., Creemers, E. E., & Pinto‐Sietsma, S. (2018) · Clinical Chemistry · doi:10.1373/clinchem.2017.285288 · Cited by 63
Quantitative proteomic analysis of the frontal cortex in Alzheimer’s disease
Sathe, G. J., Albert, M., Darrow, J. A., Saito, A., Troncoso, J. C., Pandey, A., & Moghekar, A. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15116 · Cited by 65
Surface plasmon resonance protein sensor using Vroman effect
Choi, S., Yang, Y., & Chae, J. (2008) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2008.07.036 · Cited by 65
Enhancing bottom‐up and top‐down proteomic measurements with ion mobility separations
Baker, E. S., Burnum-Johnson, K., Ibrahim, Y., Orton, D., Monroe, M. E., Kelly, R., Moore, R. J., Zhang, X., Théberge, R., Costello, C. E., et al. (2015) · PROTEOMICS · doi:10.1002/pmic.201500048 · Cited by 64
Biomarkers for Alzheimer's disease in plasma, serum and blood - conceptual and practical problems
Galasko, D. R., & Golde, T. E. (2013) · Alzheimer s Research & Therapy · doi:10.1186/alzrt164 · Cited by 64
Microfluidic-Mass Spectrometry Interfaces for Translational Proteomics
Pedde, R. D., Li, H., Borchers, C. H., & Akbari, M. (2017) · Trends in biotechnology · doi:10.1016/j.tibtech.2017.06.006 · Cited by 65
Graphene-based biosensors for the detection of prostate cancer protein biomarkers: a review
Li, X., Wen, Y., Pandit, S., Mokkapati, V. R. S. S., Mijakovic̀, I., Li, Y., Ding, M., Ren, S., Li, W., & Liu, G. (2019) · BMC Chemistry · doi:10.1186/s13065-019-0611-x · Cited by 64
Jin, L. L., Tong, J., Prakash, A., Peterman, S. M., St‐Germain, J. R., Taylor, P. P., Trudel, S., & Moran, M. F. (2010) · Journal of Proteome Research · doi:10.1021/pr100024a · Cited by 63
Recent advances in targeted proteomics for clinical applications
Domon, B., & Gallien, S. (2014) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201400136 · Cited by 63
Precision Medicine for Neonatal Sepsis
Ng, S., Strunk, T., Jiang, P., Muk, T., Sangild, P. T., & Currie, A. J. (2018) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2018.00070 · Cited by 73
Chantada‐Vázquez, M. D. P., López, A. C., García-Vence, M., Vázquez‐Estévez, S., Nebril, B. A., Calatayud, D. G., Jardiel, T., Bravo, S. B., & Núñez, C. (2019) · Journal of Proteomics · doi:10.1016/j.jprot.2019.103581 · Cited by 65
Toward a standardized urine proteome analysis methodology
Court, M., Selevsek, N., Matondo, M., Allory, Y., Garin, J., Masselon, C., & Domon, B. (2011) · PROTEOMICS · doi:10.1002/pmic.201000566 · Cited by 62
Application of Proteomics in Biomarker Discovery: a Primer for the Clinician
Tambor, V., Fučíková, A., Lenčo, J., Kacerovský, M., Řeháček, V., Stulík, J., & Pudil, R. (2010) · Physiological Research · doi:10.33549/physiolres.931758 · Cited by 62
Drake, P. M., Schilling, B., Niles, R. K., Braten, M. N., Johansen, E., Liu, H., Lerch, M., Sorensen, D. J., Li, B., Allen, S., et al. (2010) · Analytical Biochemistry · doi:10.1016/j.ab.2010.08.010 · Cited by 62
Schlatzer, D., Maahs, D. M., Chance, M. R., Dazard, J.-E., Li, X., Hazlett, F. E., Rewers, M., & Snell‐Bergeon, J. K. (2012) · Diabetes Care · doi:10.2337/dc11-1491 · Cited by 65
Iwamoto, N., & Shimada, T. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.12.007 · Cited by 68
Dewey, H. M., Lamb, A., & Budhathoki-Uprety, J. (2024) · Nanoscale · doi:10.1039/d4nr01892c · Cited by 67
The clinical impact of recent advances in LC-MS for cancer biomarker discovery and verification
Wang, H., Shi, T., Qian, W., Liu, T., Kagan, J., Srivastava, S., Smith, R. D., Rodland, K., & Camp, D. (2015) · Expert Review of Proteomics · doi:10.1586/14789450.2016.1122529 · Cited by 66
Ralhan, R., Masui, O., DeSouza, L. V., Matta, A., Macha, M. A., & Siu, K. W. M. (2011) · PROTEOMICS · doi:10.1002/pmic.201000186 · Cited by 60
Legg, K. M., Powell, R. L., Reisdorph, N. A., Reisdorph, R., & Danielson, P. B. (2016) · Electrophoresis · doi:10.1002/elps.201600352 · Cited by 61
Pre‐analytical influence on the low molecular weight cerebrospinal fluid proteome
Berven, F. S., Kroksveen, A. C., Berle, M., Rajalahti, T., Flikka, K., Arneberg, R., Myhr, K., Vedeler, C. A., Kvalheim, O. M., & Ulvik, R. J. (2007) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200700126 · Cited by 60
Plasma proteomics to identify biomarkers – application to cardiovascular diseases
Beck, H. C., Overgaard, M., & Rasmussen, L. M. (2015) · Translational Proteomics · doi:10.1016/j.trprot.2015.01.001 · Cited by 62
Pulmonary biomarkers in COPD exacerbations: a systematic review
Koutsokera, A., Κostikas, Κ., Nicod, L. P., & Fitting, J.-W. (2013) · Respiratory Research · doi:10.1186/1465-9921-14-111 · Cited by 60
Jia, W., Ren, C., Wang, L., Zhu, B., Jia, W., Gao, M., Zeng, F., Zeng, L., Xia, X., Zhang, X., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10530 · Cited by 60
Li, J., Sun, K., Chen, Z., Shi, J., Zhou, D., & Xie, G. (2016) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2016.09.078 · Cited by 60
van Remoortere, A., Jones, E. A., Deelder, A. M., & McDonnell, L. A. (2012) · Wiley eBooks · doi:10.1002/9780470921920.edm098 · Cited by 61
Cilento, E. M., Jin, L., Stewart, T., Shi, M., Sheng, L., & Zhang, J. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14635 · Cited by 60
Extending the Depth of Human Plasma Proteome Coverage Using Simple Fractionation Techniques
Kaur, G., Poljak, A., Ali, S. A., Zhong, L., Raftery, M. J., & Sachdev, P. S. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00670 · Cited by 57
Comparison of Depletion Strategies for the Enrichment of Low-Abundance Proteins in Urine
Filip, S. K., Vougas, K. N., Zoidakis, J., Latosińska, A., Mullen, W., Spasovski, G. B., Mischak, H., Vlahou, A., & Jankowski, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0133773 · Cited by 59
Lehmann, S., Hoofnagle, A. N., Hochstrasser, D. F., Brede, C., Glueckmann, M., Cocho, J. A., Ceglarek, U., Lenz, C., Vialaret, J., Scherl, A., et al. (2012) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2012-0723 · Cited by 59
Tanca, A., Pagnozzi, D., & Addis, M. F. (2011) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201100044 · Cited by 59
Contributions of immunoaffinity chromatography to deep proteome profiling of human biofluids
Wu, C., Duan, J., Liu, T., Smith, R. D., & Qian, W. (2016) · Journal of Chromatography B · doi:10.1016/j.jchromb.2016.01.015 · Cited by 59
Metadata
- Authors
- Rifai, N., Gillette, M. A., & Carr, S. A.
- Affiliations
- Boston Children's Hospital (US)
- Broad Institute (US)
- Corresponding author
- Carr, Steven A
- Venue
- Nature Biotechnology
- Published
- 2006-08
- Volume
- 24
- Issue
- 8
- Pages
- 971-983
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W2094229819
- Cited by
- 1,867
- References
- 118
- Citations by year
- 2026: 56 · 2025: 70 · 2024: 75 · 2023: 66 · 2022: 69 · 2021: 85 · 2020: 74 · 2019: 88 · 2018: 91 · 2017: 96 · 2016: 99 · 2015: 130 · 2014: 131 · 2013: 116 · 2012: 138
- FWCI
- 7.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced Biosensing Techniques and Applications
- Life Sciences › Immunology and Microbiology › Immunology › Biomarkers in Disease Mechanisms
- Keywords
- protein biomarkers, biomarker discovery, biomarker validation, mass spectrometry-based proteomics, diagnostic biomarkers, biomarker qualification, research design
- MeSH terms
- Animals, Blood Chemical Analysis, Blood Proteins, Humans, Peptide Mapping, Sensitivity and Specificity, Mass Spectrometry, Biomarkers, Protein Array Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review